International Journal of Scientific & Technology Research

Home About Us Scope Editorial Board Blog/Latest News Contact Us
10th percentile
Powered by  Scopus
Scopus coverage:
Nov 2018 to May 2020


IJSTR >> Volume 10 - Issue 10, October 2021 Edition

International Journal of Scientific & Technology Research  
International Journal of Scientific & Technology Research

Website: http://www.ijstr.org

ISSN 2277-8616

Antimicrobial Activity And Phytochemical Screening Of Split Gill Mushroom (Schizophyllum Commune) Ethanolic Extract

[Full Text]



Ricky B. Acanto, Van Helen S. Cuaderes



antimicrobial activity, ethanolic extract, macrofungi, phytochemical screening, Schizophyllum commune



Split gill mushroom (Schizophyllum commune) is one of the most widespread fungal species with various uses among communities, especially in the countryside. With its favorable characteristics, this macrofungi shows potential to be utilized in the field of natural products. The study aims to ascertain the antimicrobial effects and determine the active components present in the ethanolic extracts. The extract’s antibacterial activity was determined using Kirby-Bauer Disk Diffusion Assay, antifungal susceptibility through Poisoned Food Method, and minimum inhibitory concentration (MIC) through Microtiter Well Assay. Qualitative phytochemical analysis was carried out using the test tube method. Results revealed that gram-negative bacteria were resistant to the different concentrations of the extracts; however, gram-positive test bacteria were susceptible to any extract concentration. Additionally, MICs showed that a lower concentration of the extract was required to inhibit the growth of gram-positive than the gram-negative bacteria. The increasing concentration of extracts showed more significant fungal growth inhibition. Saponins, tannins, alkaloids, flavonoids, terpenoids, proteins, and carbohydrates were identified through the phytochemical screening. Ethanolic extracts of S. commune showed effectiveness against the growth of gram-positive bacteria and fungi due to different active components present. Further studies may be conducted to explore the potential of this macrofungi.



[1] A. L. Harvey, “Natural products in drug discovery,” Drug Discovery Today, vol. 13, no. 19–20. pp. 894–901, Oct-2008.
[2] C. Schmidt-Dannert, “Biosynthesis of terpenoid natural products in fungi,” Adv. Biochem. Eng. Biotechnol., vol. 148, pp. 19–61, 2015.
[3] A. H. S. Mirfat, S. Vikineswary, M. Ahmad, H. Salahuddin, N. Abdullah, and V. Sabaratnam, “Antimicrobial activities of split gill mushroom Schizophyllum commune Fr,” 2014.
[4] M. Kaur et al., “Schizophyllum commune induced genotoxic and cytotoxic effects in Spodoptera litura,” Sci. Rep., vol. 8, no. 1, p. 4693, Dec. 2018.
[5] J. V. Pham et al., “A Review of the Microbial Production of Bioactive Natural Products and Biologics,” Front. Microbiol., vol. 0, no. JUN, p. 1404, 2019.
[6] F. Alberti, G. D. Foster, and A. M. Bailey, “Natural products from filamentous fungi and production by heterologous expression,” Appl. Microbiol. Biotechnol. 2016 1012, vol. 101, no. 2, pp. 493–500, Dec. 2016.
[7] N. Ortega, “Kurakding fungi or Common split-gill | Project Noah,” 2012.
[8] O. Tantengco and E. M. Ragragio, “Ethnomycological survey of macrofungi utilized by Ayta communities in Bataan, Philippines,” Curr. Res. Environ. Appl. Mycol. (Journal Fungal Biol., vol. 8, no. 1, pp. 104–108, 2018.
[9] G. C. Jayakumar, S. V. Kanth, B. Chandrasekaran, J. Raghava Rao, and B. U. Nair, “Preparation and antimicrobial activity of scleraldehyde from Schizophyllum commune,” Carbohydr. Res., vol. 345, no. 15, pp. 2213–2219, Oct. 2010.
[10] A. M. Aguinaldo, E. I. Espeso, B. Q. Guevarra, and M. G. Nonato, “Phytochemistry Section,” in A Guidebook to Plant Screening: Phytochemical and Biological, 5th ed., B. Q. Guevarra, Ed. Manila: Research Center for Natural Sciences and University of Santo Tomas Publishing House, 2004, pp. 23–64.
[11] P. Tiwari, B. Kumar, M. Kaur, G. Kaur, and H. Kaur, “Phytochemical screening and Extraction: A Review,” Internalionale Pharm. Sci., vol. 1, no. 1, pp. 98–106, 2001.
[12] J. M. Andrews, “Determination of minimum inhibitory concentrations,” J. Antimicrob. Chemother., vol. 48, no. SUPPL. 1, pp. 5–16, 2001.
[13] J. Hudzicki, “Kirby-Bauer Disk Diffusion Susceptibility Test Protocol Author Information,” Am. Soc. Microbiol., no. December 2009, pp. 1–13, 2012.
[14] A. Mirfat, A. Noorlidah, and S. Vikineswary, “Scavenging activity of Schizophyllum commune extracts and its  correlation to total phenolic content,” J. Trop. Agric. Fd. Sc., vol. 38, no. 2, pp. 231–238, 2015.
[15] K. Bacon, R. Boyer, C. Denbow, S. O’Keefe, A. Neilson, and R. Williams, “Evaluation of different solvents to extract antibacterial compounds from jalapeño peppers,” Food Sci. Nutr., vol. 5, no. 3, pp. 497–503, May 2017.
[16] T. Khardziani, E. Metreveli, K. Didebulidze, and V. Elisashvili, “Screening of Georgian medicinal mushrooms for their antibacterial activity and optimization of cultivation conditions for the split gill medicinal mushroom, Schizophyllum commune BCC64 (Agaricomycetes),” Int. J. Med. Mushrooms, vol. 22, no. 7, pp. 659–669, 2020.
[17] M. Alves, I. Ferreira, J. Dias, V. Teixeira, A. Martins, and M. Pintado, “A Review on Antifungal Activity of Mushroom (Basidiomycetes) Extracts and Isolated Compounds,” Curr. Top. Med. Chem., vol. 13, no. 21, pp. 2648–2659, Dec. 2013.
[18] O. Wintola and A. Afolayan, “The antibacterial, phytochemicals and antioxidants evaluation of the root extracts of Hydnora africanaThunb. used as antidysenteric in Eastern Cape Province, South Africa,” BMC Complement. Altern. Med., vol. 15, no. 1, Sep. 2015.
[19] A. M. Tripathi and B. N. Tiwary, “Biochemical constituents of a wild strain of Schizophyllum commune isolated from Achanakmar-Amarkantak Biosphere Reserve (ABR), India,” World J. Microbiol. Biotechnol. 2013 298, vol. 29, no. 8, pp. 1431–1442, Mar. 2013.
[20] A. Kumar, M. Kumar, S. Ali, and M. P. Sinha, “Anti-pathogenic efficacy of Indian edible macrofungi Dacryopinax spathularia (Schwein) and Schizophyllum commune (Fries) against some human pathogenic bacteriae,” J. Emerg. Technol. Innov. Res., vol. 6, no. 1, pp. 695–704, 2019.
[21] L. Koroma, L. M. Kamara, T. B. R. Yormah, and G. M. T. Robert, “Phytochemical screening and antimicrobial sensitivity of extracts of the traditional medicinal plant Caloncoba echinata in Sierra Leone,” Int. J. Sci. Technol. Res., vol. 7, no. 8, pp. 1–6, 2018.
[22] M. Nikolic and S. Djordjevic, “Alkaloids in the pharmaceutical industry: Structure, isolation, and application,” Hem. Ind., vol. 57, no. 10, pp. 471–478, 2003.
[23] S. Shibata, “Saponins with Biological and Pharmacological Activity,” Springer, Berlin, Heidelberg, 1977, pp. 177–196.
[24] A. Editors, “Uses of tannins and tannosomes,” Access Sci., 2014.
[25] S. Kumar and A. K. Pandey, “Chemistry and biological activities of flavonoids: an overview.,” ScientificWorldJournal., vol. 2013, p. 162750, Dec. 2013.
[26] W. Bidigare, Robert R; Wang, Guangyi; Tang, “Terpenoids As Therapeutic Drugs and Pharmaceutical,” Nat. Prod. Drug Discov. Ther. Med., p. (197-227), 2005.
[27] Y. Luo and T. Wang, “Pharmaceutical and Cosmetic Applications of Protein By-Products,” in Protein Byproducts, Elsevier, 2016, pp. 147–160.
[28] J. Lonngren, “Carbohydrates and the pharmaceutical industry,” Pure &App/. Chem, vol. 61, no. 7, pp. 1313–1314, 1989.
[29] A. B. A. Ahmed, M. Adel, P. Karimi, and M. Peidayesh, “Pharmaceutical, Cosmeceutical, and Traditional Applications of Marine Carbohydrates,” Adv. Food Nutr. Res., vol. 73, pp. 197–220, Jan. 2014.